Matrix metalloproteinase inhibitors

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S001690, C514S019300, C514S183000, C534S010000

Reexamination Certificate

active

06989139

ABSTRACT:
Thus the present invention describes novel compounds comprising 1-10 targeting moieties; a chelator (Ch); and 0-1 linking groups (Ln) between the targeting moiety and chelator; wherein the targeting moiety is a matrix metalloproteinase inhibitor; and wherein the chelator is capable of conjugating to a cytotoxic radioisotope. The present invention also provides novel compositions of the compounds of the invention, kits and their uses in treatment of diseases associated with MMPs.

REFERENCES:
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5556939 (1996-09-01), Flanagan et al.
patent: 5646167 (1997-07-01), MacPherson et al.
patent: 5650134 (1997-07-01), Albert et al.
patent: 5674754 (1997-10-01), Ahrens et al.
patent: 6172057 (2001-01-01), Venkatesan et al.
patent: 6656448 (2003-12-01), Carpenter et al.
patent: 2002/0004032 (2002-01-01), Liu
patent: 2002/0098149 (2002-07-01), Liu
patent: 2003/0073808 (2003-04-01), Quirk et al.
patent: 0649658 (1995-04-01), None
patent: WO 97/18207 (1997-05-01), None
patent: WO 98/47541 (1998-10-01), None
patent: WO 99/18074 (1999-04-01), None
patent: WO 99/58162 (1999-11-01), None
patent: WO 99/65867 (1999-12-01), None
U.S. Appl. No. 60/195,234, filed Apr. 7, 2000.
M. Rajopadhye et al., Bioorg. Med. Chem. Lett., vol. 6, no 15, 1996, pp1737-1740.
Bakker et al. Life Sci., 1991, 49, 1583-91.
Garbisa et al., 1992, Cancer Res., 53, 4548-4549.
Matthes et al., 1992, Gastroenterology, Abstract 661.
Anthony et al., 1992, Gastroenterology, Abstract 591.
Walakovits et al., 1992, Arth. Rheum., 35, 35-42.
Zucker et al., 1993, Cancer Res. 53, 140-146.
Krenning, et al., 1993, Eur. J. Nucl. Med., 20, 716-31.
Curr. Opin. Ther. Patents 1994 4(1):7-16.
Exp. Opin. Ther. Patents 1995 5, 1087-1100.
Exp. Opin. Ther. Patents 1995 5,(12):1287-1196.
Curr. Medicinal Chem. 1995, 2, 743-762.
Krenning, et al., 1996, Digestion, 57, 57-61.
Beckett et al. 1996, Research Focus, 1, 16-26.
Summers, et al, Annual reports in Med. Chem., 1998, 33, 131-140.
Stein et al., 1999, Clin. Cancer Res., 5, 3199s-3206s.
Whittaker. et al, Chem. Rev., 1999, 99, 2735-2776.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Matrix metalloproteinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Matrix metalloproteinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix metalloproteinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3586964

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.